Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Protocol IK-4001-HRS-301: A MultiCenter, Randomized, Placebo Controlled, Double Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1, with Lucassin (Terlipressin)
Ganger, Daniel R
(PD/PI)
Flamm, Steven L
(Co-Investigator)
Medicine, Hepatology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
9/14/10
→
9/14/13
Funding
Ikaria Therapeutics, LLC
(IK-4001-HRS-301)
View all
View less